News
Lilly's Kwikpen debut intensifies rivalry with Novo Nordisk's Wegovy in the world's most populous diabetes market ...
25m
How Novo Nordisk's Weight-Loss Drug Could Unlock A Better Future For Biogen's Alzheimer's Treatment
Biogen CEO Chris Viehbacher says Novo Nordisk's Alzheimer's trial success could lead to combination therapies, boosting ...
Anna Sokolidou believes Tesla’s stock should trade at a fraction of its current price, citing fundamental weaknesses and skepticism about its self-driving technology. Meanwhile, Microsoft (MSFT) ...
Response Pharmaceuticals’ drug has helped reduce the amount of weight a patient regains after treatment with glucagon-like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback